July 13, 2017
A shareholder of life sciences contractor Albany Molecular Research Inc. sued the company in Delaware federal court on Thursday in a bid to halt its planned sale to two private equity firms, saying AMRI has failed to give investors crucial details ahead of a vote on the deal.